DIRAS3 enhances RNF19B-mediated RAC1 ubiquitination and degradation in non-small-cell lung cancer cells

[1]  Peijun Wang,et al.  GTP-binding protein Di-RAS3 diminishes the migration and invasion of non-small cell lung cancer by inhibiting the RAS/extracellular-regulated kinase pathway , 2022, Bioengineered.

[2]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  R. Bast,et al.  DIRAS3: An Imprinted Tumor Suppressor Gene that Regulates RAS and PI3K-driven Cancer Growth, Motility, Autophagy, and Tumor Dormancy , 2021, Molecular Cancer Therapeutics.

[4]  Liang Liu,et al.  Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts , 2021, Cell Death & Disease.

[5]  Shouzhen Chen,et al.  KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1 , 2021, Molecular cancer.

[6]  J. Kornbluth,et al.  Natural Killer Lytic-Associated Molecule (NKLAM): An E3 Ubiquitin Ligase With an Integral Role in Innate Immunity , 2020, Frontiers in Physiology.

[7]  H. Khan,et al.  Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma , 2020, Phytotherapy research : PTR.

[8]  E. Chastre,et al.  Rac1 Signaling: From Intestinal Homeostasis to Colorectal Cancer Metastasis , 2020, Cancers.

[9]  Ramin Rad,et al.  Dual proteome-scale networks reveal cell-specific remodeling of the human interactome , 2020, Cell.

[10]  Amy M. Hurwitz,et al.  DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters. , 2019, Cell reports.

[11]  L. Shornick,et al.  Mice deficient in NKLAM have attenuated inflammatory cytokine production in a Sendai virus pneumonia model , 2019, PloS one.

[12]  K. Rottner,et al.  The Small GTPase Rac1 Increases Cell Surface Stiffness and Enhances 3D Migration Into Extracellular Matrices , 2019, Scientific Reports.

[13]  A. Malliri,et al.  Compartmentalisation of RAC1 signalling. , 2018, Current opinion in cell biology.

[14]  Gregory Riely,et al.  Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Kornbluth,et al.  Reduced inflammation and cytokine production in NKLAM deficient mice during Streptococcus pneumoniae infection , 2018, PloS one.

[16]  R. Klevit,et al.  RING-Between-RING E3 Ligases: Emerging Themes amid the Variations. , 2017, Journal of molecular biology.

[17]  J. Kornbluth,et al.  E3 ubiquitin ligase NKLAM ubiquitinates STAT1 and positively regulates STAT1-mediated transcriptional activity. , 2016, Cellular signalling.

[18]  M. Olson.  Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors , 2016, Small GTPases.

[19]  A. Malliri,et al.  Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms , 2016, Small GTPases.

[20]  D. Levine,et al.  DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells , 2014, Autophagy.

[21]  S. Chen,et al.  IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways , 2013, Oncogene.

[22]  Xiaohong Wu,et al.  Effect of ARHI on lung cancer cell proliferation, apoptosis and invasion in vitro , 2013, Molecular Biology Reports.

[23]  R. Hoover,et al.  Natural killer lytic-associated molecule plays a role in controlling tumor dissemination and metastasis , 2012, Front. Immun..

[24]  J. Kornbluth,et al.  E3 ubiquitin ligase NKLAM is a macrophage phagosome protein and plays a role in bacterial killing. , 2012, Cellular immunology.

[25]  Carol L. Williams,et al.  The role of Rac1 in the regulation of NF-kB activity, cell proliferation, and cell migration in non-small cell lung carcinoma , 2012, Cancer biology & therapy.

[26]  Matthias Mann,et al.  Proteomic portrait of human breast cancer progression identifies novel prognostic markers. , 2012, Cancer research.

[27]  R. Bast,et al.  The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways , 2012, Oncogene.

[28]  Toshihiro Ito,et al.  Identification of Host Genes Linked with the Survivability of Chickens Infected with Recombinant Viruses Possessing H5N1 Surface Antigens from a Highly Pathogenic Avian Influenza Virus , 2011, Journal of Virology.

[29]  Q. Bu,et al.  The Expression and Clinical Significance of GTP-Binding RAS-Like 3 (ARHI) and MicroRNA 221 and 222 in Prostate Cancer , 2011, The Journal of international medical research.

[30]  R. Hoover,et al.  Impaired NK Cytolytic Activity and Enhanced Tumor Growth in NK Lytic-Associated Molecule-Deficient Mice12 , 2009, The Journal of Immunology.

[31]  L. Fiedler.  Rac1 regulates cardiovascular development and postnatal function of endothelium , 2009, Cell adhesion & migration.

[32]  Pengyuan Yang,et al.  ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis , 2009, Molecular carcinogenesis.

[33]  E. Bosco,et al.  Rac1 GTPase: A “Rac” of All Trades , 2009, Cellular and Molecular Life Sciences.

[34]  Zhen Lu,et al.  The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. , 2008, The Journal of clinical investigation.

[35]  A. Scarpa,et al.  Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors. , 2007, Neoplasia.

[36]  J. Kornbluth,et al.  NK Lytic-Associated Molecule, Involved in NK Cytotoxic Function, Is an E3 Ligase1 , 2006, The Journal of Immunology.

[37]  F. Khuri,et al.  Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. , 2004, Journal of the National Cancer Institute.

[38]  J. Bateman,et al.  Why mice have lost genes for COL21A1, STK17A, GPR145 and AHRI: evidence for gene deletion at evolutionary breakpoints in the rodent lineage. , 2004, Trends in genetics : TIG.

[39]  Ken‐ichiro Yoshida,et al.  Overexpression of RhoA, Rac1, and Cdc42 GTPases Is Associated with Progression in Testicular Cancer , 2004, Clinical Cancer Research.

[40]  X. Yao,et al.  Expression of seven main Rho family members in gastric carcinoma. , 2004, Biochemical and biophysical research communications.

[41]  R. Bast,et al.  Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. , 2003, Cancer research.

[42]  Gordon B Mills,et al.  ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers , 2003, Oncogene.

[43]  R. Bast,et al.  Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. , 2002, Cancer research.

[44]  A. Hall,et al.  Rho GTPases in cell biology , 2002, Nature.

[45]  J W Gray,et al.  NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Yang Gao,et al.  Zerumbone inhibits migration in ESCC via promoting Rac1 ubiquitination. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[47]  J. Kornbluth,et al.  E3 ubiquitin ligase NKLAM positively regulates macrophage inducible nitric oxide synthase expression. , 2015, Immunobiology.

[48]  B. Pang,et al.  EZH2-Induced H3K27me3 is Associated with Epigenetic Repression of the ARHI Tumor-Suppressor Gene in Ovarian Cancer , 2014, Cell Biochemistry and Biophysics.

[49]  Mads Thomassen,et al.  Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis , 2008, Breast Cancer Research and Treatment.